Summary
NU Advisory Partners, an AI and tech-led executive search firm, is proud to have placed Alicia Zhou, Ph.D., as Chief Executive Officer at the Cancer Research Institute (CRI). Dr. Zhou brings an impressive combination of academic prowess and industry leadership to CRI, drawing from her extensive experience as Chief Science Officer at Color Health Inc., where she led initiatives in cancer prevention and treatment.
With a strong background in cancer biology and a passion for advancing personalized medicine, Dr. Zhou’s appointment marks a new chapter for CRI’s mission to fuel breakthroughs in immunotherapy.
Quote
“I’m confident that under her direction, CRI will make great strides as we collectively work to expand the benefits of immunotherapy to more patients,” said Nobel laureate and CRI’s Scientific Advisory Council Director, Dr. James P. Allison.
Link to the Press Release
Read the press release, published on September 9, 2024, on the Cancer Research Institute website.
Our Take
We’re thrilled to have supported the Cancer Research Institute in recruiting Dr. Alicia Zhou, a visionary leader whose unique blend of scientific expertise and passion for patient impact will guide CRI through its next phase of innovation in cancer immunotherapy.
At NU Advisory Partners, we leverage cutting-edge AI tools to connect extraordinary leaders with organizations driving change in their fields. We’re honored to play a part in CRI’s continuing success in advancing cancer research.
Stay updated on our latest executive placements by following us on LinkedIn.